Holen Sie sich die Stockscreener-App
38.64
0.49%
-0.19
Handel nachbörslich:
38.55
-0.09
-0.23%
Schlusskurs vom Vortag:
$38.83
Offen:
$38.6
24-Stunden-Volumen:
744.27K
Relative Volume:
0.69
Marktkapitalisierung:
$2.98B
Einnahmen:
$13.17M
Nettoeinkommen (Verlust:
$-199.06M
KGV:
-14.10
EPS:
-2.74
Netto-Cashflow:
$-156.53M
1W Leistung:
+0.10%
1M Leistung:
+16.53%
6M Leistung:
+7.27%
1J Leistung:
-4.71%
1-Tages-Spanne:
$38.12
$38.92
1-Wochen-Bereich:
$38.00
$39.84
52-Wochen-Spanne:
$26.74
$46.00
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
Firmenname
Xenon Pharmaceuticals Inc
Sektor
Branche
Telefon
(604) 484-3300
Adresse
200 - 3650 GILMORE WAY, BURNABY
Vergleichen Sie XENE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
38.64 | 3.03B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-07 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-10-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-01-04 | Eingeleitet | Citigroup | Buy |
| 2023-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2023-04-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-14 | Eingeleitet | Goldman | Buy |
| 2022-12-12 | Eingeleitet | Cowen | Outperform |
| 2022-11-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-19 | Eingeleitet | Raymond James | Outperform |
| 2022-08-29 | Eingeleitet | BofA Securities | Buy |
| 2022-07-21 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-28 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-10-02 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-21 | Eingeleitet | Needham | Buy |
| 2020-06-01 | Fortgesetzt | Jefferies | Buy |
| 2020-03-25 | Eingeleitet | Wedbush | Outperform |
| 2020-01-08 | Eingeleitet | William Blair | Outperform |
| 2019-09-20 | Eingeleitet | Guggenheim | Buy |
| 2018-08-08 | Bestätigt | Stifel | Buy |
| 2017-03-13 | Eingeleitet | Jefferies | Buy |
| 2016-10-21 | Eingeleitet | Stifel | Buy |
| 2016-09-26 | Eingeleitet | Guggenheim | Buy |
| 2016-04-14 | Bestätigt | Jefferies | Buy |
| 2015-10-30 | Fortgesetzt | Jefferies | Buy |
| 2014-12-02 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Xenon Pharmaceuticals Inc Aktie (XENE) Neueste Nachrichten
How to build a custom watchlist for Xenon Pharmaceuticals Inc.Weekly Risk Report & High Conviction Trade Alerts - Newser
Xenon (XENE) Receives a Buy from RBC Capital - The Globe and Mail
Chart based analysis of Xenon Pharmaceuticals Inc. trendsJuly 2025 Update & Free Long-Term Investment Growth Plans - Newser
Building trade automation scripts for Xenon Pharmaceuticals Inc.July 2025 Review & Consistent Profit Trade Alerts - Newser
Applying Elliott Wave Theory to Xenon Pharmaceuticals Inc.2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
Published on: 2025-09-03 01:33:36 - Newser
Ranking Xenon Pharmaceuticals Inc. among high performing stocks via toolsJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - Newser
Can swing trading help recover from Xenon Pharmaceuticals Inc. lossesIPO Watch & Fast Moving Market Watchlists - Newser
Using AI based signals to follow Xenon Pharmaceuticals Inc.CPI Data & AI Powered Buy and Sell Recommendations - Newser
Predicting Xenon Pharmaceuticals Inc. trend using moving averagesBuy Signal & Safe Capital Growth Plans - Newser
Volume Recap: Can Xenon Pharmaceuticals Inc. navigate macro headwindsQuarterly Investment Review & Real-Time Chart Breakout Alerts - khodrobank.com
Developing predictive dashboards with Xenon Pharmaceuticals Inc. dataPortfolio Performance Summary & Weekly Market Pulse Alerts - Newser
What is Xenon Pharmaceuticals Inc.’s book value per sharePortfolio Update Summary & Real-Time Volume Triggers - khodrobank.com
Price momentum metrics for Xenon Pharmaceuticals Inc. explainedJuly 2025 Decliners & Weekly Top Gainers Alerts - Newser
Xenon Pharmaceuticals shares fall 1.50% premarket after equity inducement grants to new employees. - AInvest
RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug - MSN
Understanding Xenon Pharmaceuticals Inc.’s price movementGap Up & Weekly High Conviction Ideas - Newser
Is Xenon Pharmaceuticals Inc. reversing from oversold territory2025 Trading Recap & Intraday High Probability Alerts - Newser
Using RSI to spot recovery in Xenon Pharmaceuticals Inc.2025 Trading Volume Trends & Community Verified Swing Trade Signals - Newser
Xenon Pharmaceuticals Q2 Earnings Call Highlights Strong Progress and Promising Future - AInvest
Xenon Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - MarketScreener
What dividend growth rate does Xenon Pharmaceuticals Inc. offerWeekly Stock Summary & Weekly Watchlist for Hot Stocks - khodrobank.com
Can machine learning forecast Xenon Pharmaceuticals Inc. recoveryJuly 2025 Decliners & High Conviction Buy Zone Picks - Newser
How to integrate Xenon Pharmaceuticals Inc. into portfolio analysis toolsTreasury Yields & Fast Exit and Entry Trade Guides - Newser
Is Xenon Pharmaceuticals Inc. stock reversal real or fakeEarnings Beat & AI Enhanced Trading Alerts - Newser
Key resistance and support levels for Xenon Pharmaceuticals Inc.2025 Price Action Summary & Fast Entry and Exit Trade Plans - Newser
Using fundamentals and technicals on Xenon Pharmaceuticals Inc.Market Movement Recap & Safe Entry Zone Identification - Newser
Xenon Pharmaceuticals Inc. stock volume spike explainedQuarterly Portfolio Summary & Daily Stock Trend Watchlist - Newser
Xenon Pharmaceuticals Inc. Shows Early Signs of Technical Strength getLinesFromResByArray error: size == 0 - thegnnews.com
Xenon Pharmaceuticals Inc. stock trendline breakdown2025 Short Interest & High Return Trade Guides - Newser
Can volume confirm reversal in Xenon Pharmaceuticals Inc.Weekly Trade Review & Expert Verified Stock Movement Alerts - Newser
Momentum divergence signals in Xenon Pharmaceuticals Inc. chart2025 Earnings Impact & Real-Time Volume Surge Alerts - Newser
Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Xenon Pharmaceuticals Inc-Aktie (XENE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GANNON STEVEN | Director |
May 14 '25 |
Option Exercise |
12.57 |
5,144 |
64,660 |
7,144 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 24 '25 |
Option Exercise |
17.76 |
22,468 |
399,032 |
53,770 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 27 '25 |
Option Exercise |
17.76 |
16,315 |
289,754 |
46,468 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 23 '25 |
Option Exercise |
17.76 |
16,217 |
288,014 |
47,519 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 24 '25 |
Sale |
40.20 |
22,468 |
903,214 |
31,302 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 27 '25 |
Sale |
40.50 |
16,315 |
660,806 |
31,302 |
| MORTIMER IAN | PRESIDENT & CEO |
Jan 23 '25 |
Sale |
40.08 |
16,217 |
649,977 |
31,302 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):